{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:26:43Z","timestamp":1794508003437,"version":"4.9.1"},"reference-count":32,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2004,9,7]],"date-time":"2004-09-07T00:00:00Z","timestamp":1094515200000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2004,9]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold>The expected annual cost (in the year 2000 prices) for a 30\u2010year\u2010old patient with average individual and treatment characteristics for on\u2010demand EUR 51\u2003832 (95% CI: 44\u2003324\u201359\u2003341) and for prophylaxis EUR 146\u2003118 (95% CI: 129\u2003965\u2013162\u2003271), was obtained from panel\u2010data analysis of an 11\u2010year retrospective panel of 156 patients with severe haemophilia in Norway and Sweden. Costs included haemophilia\u2010related treatment costs within the health\u2010care sector (factor concentrate, doctors\u2019 visits, diagnostic procedures, hospitalisation, invasive procedures, etc.) and cost for haemophilia\u2010related resource use in other sectors (lost production, use of special equipment, adaptation of workplace and domicile, etc). Although costs of lost production, reconstructive surgery and hospitalisation were higher for on\u2010demand, they did not balance out the higher costs of factor\u2010concentrate consumption in prophylaxis. The cut\u2010off risk of premature death, where on\u2010demand and prophylaxis would have been equally costly, was 3.7 percentage units higher for on\u2010demand than for prophylaxis. Such a great risk difference has not been reported elsewhere to our knowledge. Estimated cost\u2010elasticities indicated that annual costs of prophylaxis would increase by approximately the same proportion as a potential increase in the price of factor concentrate and decrease less than proportionately with a reduction in prescribed dose kg<jats:sup>\u22121<\/jats:sup>. For on\u2010demand, the annual costs would increase by approximately the same proportion as an increase in the prescribed dose kg<jats:sup>\u22121<\/jats:sup>.<\/jats:p>","DOI":"10.1111\/j.1365-2516.2004.00952.x","type":"journal-article","created":{"date-parts":[[2004,9,7]],"date-time":"2004-09-07T13:49:52Z","timestamp":1094564992000},"page":"515-526","source":"Crossref","is-referenced-by-count":38,"title":["Costs of on\u2010demand and prophylactic treatment for severe haemophilia in Norway and Sweden"],"prefix":"10.1111","volume":"10","author":[{"given":"K. STEEN","family":"Carlsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"H\u00f6jg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lindgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lethagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Schulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Glomstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Tengborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Berntorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Lindgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,9,7]]},"reference":[{"key":"e_1_2_15_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.9.s1.17.x"},{"key":"e_1_2_15_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1994.tb00815.x"},{"key":"e_1_2_15_4_2","volume-title":"Hemophilia","author":"Nilsson I\u2010M.","year":"1994"},{"key":"e_1_2_15_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2000.00427.x"},{"key":"e_1_2_15_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2003.00817.x"},{"key":"e_1_2_15_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.1995.tb00103.x"},{"key":"e_1_2_15_8_2","volume-title":"Pharmacokinetic Dosing of Factor VIII and Factor IX in Prophylactic Treatment of Haemophilia, in Department for Coagulation Disorders (Department of Medicine)","author":"Carlsson M.","year":"1997"},{"key":"e_1_2_15_9_2","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1001\/archinte.1970.00310060082008","article-title":"Hemophilia prophylaxis with factor VIII concentrate","volume":"125","author":"Kasper C","year":"1970","journal-title":"Arch Intern Med"},{"key":"e_1_2_15_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199123000-00006"},{"issue":"2","key":"e_1_2_15_11_2","first-page":"5","article-title":"Prophylactic treatment of severe hemophilia A and B can prevent joint disability","volume":"31","author":"Nilsson I","year":"1994","journal-title":"Semin Hematol"},{"key":"e_1_2_15_12_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462300006930"},{"key":"e_1_2_15_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2000.00633.x"},{"key":"e_1_2_15_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2002.00580.x"},{"key":"e_1_2_15_15_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200220110-00005"},{"key":"e_1_2_15_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1355-0691.2004.00878.x"},{"key":"e_1_2_15_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00954.x"},{"key":"e_1_2_15_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1999.00368.x"},{"key":"e_1_2_15_19_2","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond M","year":"1997"},{"key":"e_1_2_15_20_2","volume-title":"Human Capital. A Theoretical and Empirical Analysis, with Special Reference to Education","author":"Becker G.","year":"1975"},{"key":"e_1_2_15_21_2","volume-title":"Econometric Analysis of Panel Data","author":"Baltagi B.","year":"1995"},{"key":"e_1_2_15_22_2","volume-title":"Benefit\u2010Cost Analysis in Theory and Practice","author":"Zerbe R","year":"1994"},{"key":"e_1_2_15_23_2","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195072785.001.0001","volume-title":"Fatal Tradeoffs: Public and Private Responsibilities for Risk","author":"Viscusi K.","year":"1992"},{"key":"e_1_2_15_24_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011180018244"},{"key":"e_1_2_15_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2002.00695.x"},{"key":"e_1_2_15_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1998.00179.x"},{"key":"e_1_2_15_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91593-B"},{"key":"e_1_2_15_28_2","first-page":"2428","article-title":"A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group","volume":"83","author":"Bray G","year":"1994","journal-title":"Blood"},{"key":"e_1_2_15_29_2","first-page":"453","volume-title":"N Engl J Med","author":"Lusher JM","year":"1993"},{"key":"e_1_2_15_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1992.tb00546.x"},{"key":"e_1_2_15_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1987.tb01173.x"},{"key":"e_1_2_15_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2002.00694.x"},{"key":"e_1_2_15_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.9.s1.15.x"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2004.00952.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2004.00952.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T09:18:59Z","timestamp":1705223939000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2004.00952.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["10.1111\/j.1365-2516.2004.00952.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2004.00952.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}